UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
61.
Bisphosphonates: Molecular mechanisms of action and effects on bone cells, monocytes and macrophages
Current pharmaceutical design, ISSN 1381-6128, 2010, Volume 16, Issue 27, pp. 2950 - 2960
Bisphosphonate | Fpp synthase | Monocyte | Bone affinity | Protein prenylation | Osteoclast | Osteocyte | Macrophage | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Calcium - metabolism | Humans | Monocytes - metabolism | Bone and Bones - drug effects | Tissue Distribution | Chelating Agents - pharmacokinetics | Bone and Bones - metabolism | Drug Design | Diphosphonates - therapeutic use | Bone Density Conservation Agents - metabolism | Chelating Agents - therapeutic use | Bone Density Conservation Agents - pharmacokinetics | Bone Resorption - drug therapy | Bone Density Conservation Agents - therapeutic use | Diphosphonates - pharmacokinetics | Diphosphonates - metabolism | Chelating Agents - pharmacology | Organ Specificity | Bone Density Conservation Agents - pharmacology | Monocytes - drug effects | Macrophages - metabolism | Animals | Macrophages - drug effects | Chelating Agents - metabolism | Diphosphonates - pharmacology | Drugs | Enzymes | Animal models | Cytotoxicity | Osteocytes | Bone diseases | Minerals | Macrophages | Bisphosphonates | Survival | Clodronic acid | Bone resorption | Paget's disease | Monocytes | Osteoclasts | Skeleton | ATP | Apoptosis | Guanosinetriphosphatase
Journal Article
62.
Tacrine-based multifunctional agents in Alzheimer's disease: an old story in continuous development
Current medicinal chemistry, ISSN 0929-8673, 2017, Volume 24, Issue 32, pp. 1 - 25
Acetylcholinesterase inhibitors | Dual binding acetylcholinesterase inhibitors | Neurodegenerative diseases | Alzheimer's Disease | Tacrine hybrids | Tacrine | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Reactive Oxygen Species - metabolism | Humans | Chelating Agents - chemistry | Cholinesterase Inhibitors - chemistry | Alzheimer Disease - drug therapy | Alzheimer Disease - enzymology | Chelating Agents - pharmacology | Drug Discovery | Tacrine - therapeutic use | Tacrine - pharmacology | Animals | Cholinesterase Inhibitors - pharmacology | Butyrylcholinesterase - metabolism | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Ligands | Cholinesterase Inhibitors - therapeutic use | Tacrine - analogs & derivatives | Chelating Agents - therapeutic use | Acetylcholinesterase - metabolism | Reactive oxygen species | Acetylcholinesterase | Cholinesterase | Blockage | Literature reviews | Reviews | Chelation | β-Amyloid | Alzheimers disease | Alzheimer's disease | Secretase | Bibliographic data bases
Journal Article
Cochrane library, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD007476 - CD007476
HAEMOGLOBINOPATHIES | TREATMENT | Deferiprone | Deferoxamine | Patient Satisfaction | Clinical Trials, Phase III as Topic | Triazoles | Child health | BLOOD | Benzoates | Genetic disorders | THALASSAEMIA | Administration, Oral | Erythrocyte Transfusion | Pyridones | Thalassemia | IRON CHELATION | Randomized Controlled Trials as Topic | Deferasirox | Blood disorders | Iron Chelating Agents | Medicine General & Introductory Medical Sciences | Ferritins | Clinical Trials, Phase II as Topic | Iron Overload | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Index Medicus
Journal Article
American journal of hematology, ISSN 0361-8609, 06/2017, Volume 92, Issue 6, pp. E88 - E91
Life Sciences & Biomedicine | Hematology | Science & Technology | Benzoates - adverse effects | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Benzoates - chemistry | Humans | Recombinant Fusion Proteins - therapeutic use | Male | Thrombopoietin - therapeutic use | Anemia, Iron-Deficiency - blood | Iron Chelating Agents - chemistry | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Young Adult | Hydrazines - chemistry | Pyrazoles - chemistry | Ferritins - blood | Female | Molecular Structure | Drug Therapy, Combination | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Iron Chelating Agents - therapeutic use | Iron - metabolism | Anemia, Iron-Deficiency - chemically induced | Iron Chelating Agents - adverse effects | Platelet Count | Adolescent | Hydrazines - adverse effects | Thrombocytopenia | Idiopathic thrombocytopenic purpura | Nutrient deficiency | Index Medicus
Journal Article
Food and chemical toxicology, ISSN 0278-6915, 09/2013, Volume 59, pp. 485 - 491
CCl4-induced hepatotoxicity | Free radical scavenger | iNOS | Anti-inflammatory | Nymphaea pubescens | Carrageenan-induced paw edema | INOS | Food Science & Technology | Toxicology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Phenols - isolation & purification | Flowers - chemistry | Carbon Tetrachloride Poisoning - prevention & control | Dietary Supplements - analysis | Liver - immunology | Plant Extracts - metabolism | Liver - drug effects | Saponins - therapeutic use | Free Radical Scavengers - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Chelating Agents - therapeutic use | Subcutaneous Tissue - metabolism | Edema - prevention & control | Liver - metabolism | Rats | Plant Extracts - isolation & purification | Random Allocation | Free Radical Scavengers - isolation & purification | India | Edema - metabolism | Carbon Tetrachloride Poisoning - blood | Ethnopharmacology | Macrophages - metabolism | Saponins - isolation & purification | Chelating Agents - isolation & purification | Subcutaneous Tissue - immunology | Flavonoids - isolation & purification | Mice | Saponins - metabolism | Plant Extracts - therapeutic use | Saponins - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - isolation & purification | Flavonoids - therapeutic use | Plant Extracts - administration & dosage | Carbon Tetrachloride Poisoning - metabolism | Flavonoids - administration & dosage | Nymphaea - chemistry | Macrophages - immunology | Edema - immunology | Free Radical Scavengers - metabolism | Cells, Cultured | Free Radical Scavengers - administration & dosage | Macrophages - cytology | Phenols - metabolism | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Flavonoids - metabolism | Phenols - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Carbon Tetrachloride Poisoning - immunology | Phenols - administration & dosage | Chelating Agents - metabolism | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 18, pp. 3657 - 3669
Life Sciences & Biomedicine | Hematology | Science & Technology | Deferasirox | Iron Overload - etiology | Iron Chelating Agents - therapeutic use | Benzoates - therapeutic use | Iron Overload - drug therapy | Humans | Deferoxamine - therapeutic use | Deferiprone | Pyridones - therapeutic use | Hematologic Diseases - therapy | Transfusion Reaction | Triazoles - therapeutic use
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 7/2011, Volume 71, Issue 10, pp. 1281 - 1320
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | diabetic arteriopathy | heart failure | selective copper chelation | diabetic neuropathy | diabetic retinopathy | organ regeneration | arteriosclerosis | Copper overload | triethylenetetramine | experimental therapeutics | iron | randomized clinical trials | Alzheimers disease | diabetes | experimental pharmacology | zinc | diabetic nephropathy | oxidative stress | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Neurology | Organic mental disorders. Neuropsychology | Diabetes. Impaired glucose tolerance | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychopathology. Psychiatry | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Alzheimer Disease - physiopathology | Diabetes Complications - physiopathology | Humans | Diabetes Mellitus - drug therapy | Alzheimer Disease - drug therapy | Diabetes Complications - drug therapy | Chelating Agents - pharmacology | Trientine - pharmacology | Drug Delivery Systems | Trientine - therapeutic use | Animals | Diabetes Mellitus - physiopathology | Copper - metabolism | Chelating Agents - therapeutic use | Research | Diabetes | Drug therapy | Polyamines | Alzheimer's disease | Health aspects | Index Medicus
Journal Article